Natural History of the Progression of X-Linked Retinitis Pigmentosa

CompletedOBSERVATIONAL
Enrollment

201

Participants

Timeline

Start Date

September 13, 2017

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions
X-Linked Retinitis Pigmentosa
Interventions
OTHER

Other: Assessments

Administered as specified in the treatment arm.

Trial Locations (22)

10032

Research Site, New York

33136

Research Site, Miami

53705

Research Site, Madison

75231

Research Site, Dallas

77030

Research Site, Houston

84132

Research Site, Salt Lake City

85020

Research Site, Phoenix

90095

Research Site, Los Angeles

94143

Research Site, San Francisco

97239

Research Site, Portland

H4A 3J1

Research Site, Montreal

V5Z3N9

Research Site, Vancouver

Unknown

Research Site, Helsinki

Research Site, Montpellier

Research Site, Bonn

Research Site, Tübingen

Research Site, Leiden

Research Site, Nijmegen

Research Site, Leeds

Research Site, Manchester

Research Site, Oxford

Research Site, Southampton

All Listed Sponsors
lead

NightstaRx Ltd, a Biogen Company

OTHER

NCT04926129 - Natural History of the Progression of X-Linked Retinitis Pigmentosa | Biotech Hunter | Biotech Hunter